检索结果 - Jason J. Luke

Refine Results
  1. 1
    Considering adjuvant therapy for stage II melanoma

    Considering adjuvant therapy for stage II melanoma 由 Andrew Poklepovic, Jason J. Luke

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response

    Dendritic Cells, the T-cell-inflamed Tumor Microenvironment, and Immunotherapy Treatment Response 由 Christopher Garris, Jason J. Luke

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma

    PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma 由 Jason J. Luke, Patrick A. Ott

    出版 2015
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Chemotherapy in the management of advanced cutaneous malignant melanoma

    Chemotherapy in the management of advanced cutaneous malignant melanoma 由 Jason J. Luke, Gary K. Schwartz

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma

    Ipilimumab, Vemurafenib, Dabrafenib, and Trametinib: Synergistic Competitors in the Clinical Management of BRAF Mutant Malignant Melanoma 由 Jason J. Luke, F. Stephen Hodi

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis

    Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis 由 Brian Labadie, Riyue Bao, Jason J. Luke

    出版 2018
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  7. 7
    <p>Toll-Like Receptor 9 Agonists in Cancer</p>

    <p>Toll-Like Receptor 9 Agonists in Cancer</p> 由 Lilit Karapetyan, Jason J. Luke, Diwakar Davar

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types

    Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types 由 Riyue Bao, Daniel Stapor, Jason J. Luke

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy

    Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy 由 Claudia Trojaniello, Jason J. Luke, Paolo A. Ascierto

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    Targeting Cbl-b in cancer immunotherapy

    Targeting Cbl-b in cancer immunotherapy 由 Ryan C. Augustin, Riyue Bao, Jason J. Luke

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery

    High Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery 由 Jessica Zielinski, Jason J. Luke, Silvia Guglietta, Carsten Krieg

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  12. 12
    T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection

    T Cell–Inflamed versus Non-T Cell–Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection 由 Jonathan Trujillo, Randy F. Sweis, Riyue Bao, Jason J. Luke

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    <i>ACE2</i>and<i>TMPRSS2</i>expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19

    <i>ACE2</i>and<i>TMPRSS2</i>expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19 由 Riyue Bao, Kyle M. Hernandez, Lei Huang, Jason J. Luke

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    STING Agonists as Cancer Therapeutics

    STING Agonists as Cancer Therapeutics 由 Afsaneh Amouzegar, Manoj Chelvanambi, J Filderman, Walter J. Storkus, Jason J. Luke

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  15. 15
    WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers

    WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers 由 Jason J. Luke, Riyue Bao, Randy F. Sweis, Stefani Spranger, Thomas F. Gajewski

    出版 2019
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    STING pathway agonism as a cancer therapeutic

    STING pathway agonism as a cancer therapeutic 由 Blake Flood, Emily F. Higgs, Shuyin Li, Jason J. Luke, Thomas F. Gajewski

    出版 2019
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  17. 17
    Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies

    Complete response of metastatic melanoma in a patient with Crohn’s disease simultaneously receiving anti-α4β7 and anti-PD1 antibodies 由 Christopher C. Frohne, Ernesto M. Llano, Ashley Perkovic, Russell D. Cohen, Jason J. Luke

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Clinical Response of a Patient to Anti–PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors

    Clinical Response of a Patient to Anti–PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors 由 Shalin Shah, James E. Ward, Riyue Bao, Curtis R. Hall, Bruce Brockstein, Jason J. Luke

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy

    Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy 由 Ryan C. Augustin, Robert D. Leone, Aung Naing, Lawrence Fong, Riyue Bao, Jason J. Luke

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  20. 20
    The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients

    The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients 由 Vyara Matson, Jessica Fessler, Riyue Bao, Tara Chongsuwat, Yuanyuan Zha, Maria‐Luisa Alegre, Jason J. Luke, Thomas F. Gajewski

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: